Early Stage Scoliosis Intervention Program Uses Scoliscore Genetic Testing to Eliminate the Need For Scoliosis Brace Treatment and Scoliosis Surgery In The Future

Online, March 22, 2011 (Newswire.com) - (Lititz, Pennsylvania) Dr. Clayton Stitzel, former Co-director of the CLEAR Institute, (a non-profit scoliosis research think tank) and Dr. Brian Dovorany, of Green Bay, WI (Current Chairman of Education for the CLEAR Institute) have released their vision for how the new Scoliscore genetic test for idiopathic scoliosis combined with a newly developed early stage scoliosis intervention program could reform the entire scoliosis treatment system in the future.

The re-invented scoliosis treatment protocol centers patient treatment around each patient's own genetic pre-disposition for the disease using the prognostic genetic testing developed by Axial Bio-Tech almost 2 years ago; instead of the traditional cobb angle measurements which have been the medical standard since 1948.

Scoliosis occurs when the spine of the back forms a C or an S shaped curve. Scoliosis affects 2 to 3 percent of the population (an estimated 6 million people worldwide) and there is no cure. Scoliosis impacts infants, adolescents, and adults worldwide. The primary age of onset for scoliosis is 10 to 15 years old, and the condition affects more females than males. Females are more likely to progress to a curve magnitude that requires treatment. Scoliosis can impact the quality of life with limited activity, pain, reduced respiratory function or diminished self-esteem.

Drs. Stitzel and Dovoray have been utilizing this new protocol and genetic testing for over a year now. Dr. Stitzel elaborates, "The current system of scoliosis evaluation and treatment hasn't be updated in over 60 years and the advent of genetic testing and the soon-to-be-release scoliosis blood test will make the current reactive approach to scoliosis treatment obsolete very quickly. Our early stage scoliosis intervention program allows the most at risk idiopathic scoliosis patients to begin treatment before the curve even starts."

Drs. Stitzel and Dovorany have released a 90 second FLASH presentation explaining how the Scoliscore genetic test and Early Stage Scoliosis Intervention are combined in an effort to "re-invent" the future of scoliosis treatment. "The role of genetics and environment on scoliosis" presentation is available for viewing at http://www.treatingscoliosis.com/early-stage.html .

Dr. Clayton Stitzel is a Lancaster County Native. He is a graduate of Manheim Central High School. He received his bachelor's degree in Kinesiology (the advanced study of biomechanics) from Penn State University. Dr. Stitzel earned his Doctor of Chiropractic degree from Palmer College of Chiropractic in Davenport, Iowa. While attending Palmer College of Chiropractic, he received research honors and was inducted into Palmer's research fraternity. He is one of nine health care professionals within the U.S. that have received the CLEAR Institute's most prestigious certification in scoliosis treatment- scoliosis intensive care certified. Dr. Stitzel is a nationally and internationally recognized lecturer within the scoliosis field, speaking recently in Singapore and England. He is the co-developer of the scoliosis traction chair. Dr. Stitzel is the owner and Clinic Director for the Lancaster Spinal Health Center where he has practiced for 9 years.

Dr Dovorany graduated cum-laude and received recognition for clinical excellence from Palmer College in 1997 and has practiced for over 11 years in Green Bay,WI. Dr Dovorany specializes in scoliosis care and currently holds a position on the board of advisors for CLEAR-Institute as chairman of the doctor education committee.

The Posture and Spine Care Center strives to provide alternative, non-invasive treatment options for scoliosis patients who may feel they don't have any options other than bracing or surgery.